REGENXBIO Inc. (RGNX)
NASDAQ: RGNX
· Real-Time Price · USD
7.52
0.37 (5.17%)
At close: May 09, 2025, 3:59 PM
7.40
-1.60%
After-hours: May 09, 2025, 05:50 PM EDT
5.17% (1D)
| Bid | 7.15 |
| Market Cap | 376.88M |
| Revenue (ttm) | 83.33M |
| Net Income (ttm) | -227.1M |
| EPS (ttm) | -4.59 |
| PE Ratio (ttm) | -1.64 |
| Forward PE | -6.81 |
| Analyst | Buy |
| Ask | 7.8 |
| Volume | 766,450 |
| Avg. Volume (20D) | 996,031 |
| Open | 7.23 |
| Previous Close | 7.15 |
| Day's Range | 7.23 - 7.78 |
| 52-Week Range | 5.04 - 16.85 |
| Beta | 1.11 |
About RGNX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RGNX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RGNX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
REGENXBIO Inc. is scheduled to release its earnings on May 12, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+8.97%
REGENXBIO shares are trading higher after the comp...
Unlock content with
Pro Subscription
2 months ago
-7.1%
Regenxbio shares are trading lower after Goldman Sachs downgraded the stock from Buy to Neutral and cut its price target from $38 to $14.
